Status:
COMPLETED
SMART Dressing for Hypertrophic Scar Treatment Post-Total Knee/Hip Arthroplasty
Lead Sponsor:
Chinese University of Hong Kong
Collaborating Sponsors:
The Hong Kong Polytechnic University
Conditions:
Knee Arthropathy
Hip Arthropathy
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
Pressure therapy (PT) and silicone therapy are recommended as first-line non-invasive treatment for Hypertrophic Scar (HS), yet the effectiveness of the combination of these two treatments through an ...
Detailed Description
Hypertrophic scar (HS) is a challenging yet common complication of dermal injuries such as burns, surgeries, and trauma. It is characterized as a raised, rigid, hyper-vascular, and abnormally pigmente...
Eligibility Criteria
Inclusion
- Adult (age over 18 years old) undergoing TKR and THR within 6 weeks;
- Adult who is able to provide written consent, is cooperative and compliant with the treatment and assessment regime;
- The Vancouver Scar Scale (VSS) will be used to screen candidates for the study.10 Isolated scars with a total score of 4 or higher and the score of each item equal to or greater than 1 will be included.
Exclusion
- The HS area has an open wound or infection, or HS area is local flap or skin graft area;
- The HS area intends to be treated with steroid injections or other interventions (such as traditional Chinese medicine or laser therapy)
- The patients with co-morbidities that might affect their compliance to treatment such as dermatological disorders.
Key Trial Info
Start Date :
January 31 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03849274
Start Date
January 31 2020
End Date
July 31 2021
Last Update
March 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Orthopaedics & Traumatology
Hong Kong, Hong Kong